Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

654

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma, Bronchial

Interventions

DRUG: Symbicort (budesonide/formoterol) Turbuhaler
DRUG: Conventional treatment

Sponsor

AstraZeneca